TP53BP2 and metabolic dysfunction-associated steatotic liver disease: In the present study, we investigated the effect of ASPP2 on gut microbiota and hepatic fatty acid homeostasis in early and later-stage of NAFLD by multi-omics analysis using MCD-induced ASPP2-deficient mice.